Back
Science

Rare Genetic Mimics Infrequently Affect MS Diagnosis or Severity, Large Study Concludes

Generated on: Last updated: 1 sources
View source

Rare Genetic Changes and MS: Insights from the ANZgene Consortium

Multiple Sclerosis (MS) is an immune-mediated disease impacting the brain and spinal cord, with various risk factors, including genetics. Diagnosing MS can be complex, as some rare neurological conditions can present similarly or occur alongside MS, posing significant challenges.

Investigating Genetic Links in MS

The Australia and New Zealand MS Genetics Consortium (ANZgene) aimed to clarify these complexities. Their study, involving 4,340 individuals with MS and 2,861 without MS, sought to determine whether rare genetic changes, typically associated with other neurological diseases, influence MS risk or severity.

Study Design and Methodology

Researchers collected genetic data from participants attending specialist MS clinics across Australia and New Zealand. Their analysis meticulously focused on the protein-coding regions of DNA, specifically examining 1,680 genes already known to cause other progressive brain and nerve conditions. The goal was to pinpoint any rare genetic variations.

When significant changes were identified, experienced MS neurologists conducted thorough reviews of the individuals' clinical histories and MRI scans. The research team also meticulously compared genetic patterns:

  • Between the MS and non-MS groups.
  • Between individuals experiencing milder versus more severe forms of MS.

Key Findings Unveiled

The study yielded reassuring results regarding genetic mimics and co-occurring conditions. Out of 75 individuals with MS who displayed significant genetic changes and had detailed histories available, only four showed clear evidence of either:

  • A genetic "mimic" disease instead of MS.
  • A separate genetic disease alongside MS.

This indicates that true genetic mimics or additional rare genetic diseases are exceptionally uncommon in specialist MS clinics.

Furthermore, the study found no substantial evidence suggesting that rare genetic changes within the 1,680 genes analyzed were more prevalent in people with MS, nor were they linked to increased MS severity.

Reassurance and Clinical Implications

These findings offer considerable reassurance for individuals living with MS. They strongly suggest that misdiagnosis due to a genetic mimic or the presence of an additional rare genetic disease is infrequent when patients are managed in specialist MS clinics.

The study implies that rare genetic changes in genes associated with other neurological conditions contribute minimally to MS development or its severity.

However, the research also acknowledges a crucial nuance: a small number of individuals may indeed have an MS-resembling genetic disease or MS combined with another genetic condition. This underscores the enduring necessity of considering "red flags" in symptoms, MRI findings, and family history.

For individuals presenting with unusual clinical presentations, atypical scans, or strong family histories, targeted clinical genetic testing may still prove beneficial. Such testing can guide appropriate treatment strategies and support essential genetic counseling.